In recent studies evaluating the usefulness of the matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS)-based identification of yeasts for the routine diagnosis of fungal infections, preanalytical sample processing has emerged as a critical step for reliable MALDI-TOF MS outcomes, especially when the Bruker Daltonics Biotyper software was used. In addition, inadequate results often occurred due to discrepancies between the methods used for clinical testing and database construction. Therefore, we created an in-house MALDI-TOF MS library using the spectra from 156 reference and clinical yeast isolates (48 species in 11 genera), which were generated with a fast sample preparation procedure. After a retrospective validation study, our database was evaluated on 4,232 yeasts routinely isolated during a 6-month period and fast prepared for MALDI-TOF MS analysis. Thus, 4,209 (99.5%) of the isolates were successfully identified to the species level (with scores of >2.0), with 1,676 (39.6%) having scores of >2.3. For the remaining 23 (0.5%) isolates, no reliable identification (with scores of <1.7) was obtained. Interestingly, these isolates were almost always from species uniquely represented or not included in the database. As the MALDI-TOF MS results were, except for 23 isolates, validated without additional phenotypic or molecular tests, our proposed strategy can enhance the rapidity and accuracy of MALDI-TOF MS in identifying medically important yeast species. However, while continuous updating of our database will be necessary to enrich it with more strains/species of new and emerging yeasts, the present in-house MALDI-TOF MS library can be made publicly available for future multicenter studies.T o date, literature-based evidence has accumulated with respect to the reliability of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for the identification of yeast isolates in diagnostic clinical microbiology laboratories (1-10). As already shown with bacteria, MALDI-TOF MS identifies yeasts with rapidity, accuracy, and superiority over conventional phenotypic methods (for review, see references 11-15).As an alternative to the ethanol/formic acid-based procedure, also referred to as complete tube extraction, recommended for use only with the Bruker MALDI Biotyper system (Bruker Daltonics, Bremen, Germany), the on-plate extraction or fast formic acid method (4, 16, 17), which consists of covering the smeared yeast colony with a formic acid solution, was proposed. Using the Bruker Biotyper 3.0 database and spectral scores of Ն1.7 as cutoffs for species-level identification, Theel et al. found that the formic acid-based direct on-plate method yielded identification percentages that were similar to those obtained with the more complex tube-based extraction method (18). Nonetheless, Van Herendael et al. showed that MALDI-TOF MS analysis using the short extraction method is suitable for the rapid identification of yeast isolates but that its use ...